ALOX15 and Parkinson disease: Hence, the madopar, which supplements the insufficient neurotransmitter dopamine, is the major treatment for PD patients and was the positive drug in this study.44 In addition, the greater efficacy of baicalein as an Alox15 inhibitor on motor and tremor performance in Mix subtype of PD suggests that these targets deserve attention and further investigation.